alexa
Reach Us +441902928240
Ian F Robey | OMICS International
ISSN: 2329-6771

Journal of Integrative Oncology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Ian F Robey

Ian F Robey Ian F Robey,
Arizona Respiratory Center,
University of Arizona
1501 N. Campbell Ave, Suite 2349, PO Box 245030
Tucson Arizona, 85724, USA

Biography

Ian Robey, PhD, is a Research Assistant Professor with the Department of Medicine, University of Arizona, and a Full Investigator at the Arizona Cancer Center. Dr. Robey is a new investigator studying the role of pH in tumor behavior. He is interested in the mechanisms driving acid-mediated invasion and metastases and how pH modulation can be used for therapeutic purposes in cancer treatment.

Research Interest

The purpose of my research program is to improve understanding on how extracellular pH influences tumor behavior. I am interested in the mechanisms driving acid-mediated invasion and metastases. Another major goal of my studies is to determine if systemic alkaline buffering is effective as an interventional or adjunctive therapy in the treatment of metastatic cancer. My initial research focus has been on the role of glycolysis, acidity, and hypoxia in tumor progression. These investigations placed a strong emphasis on imaging techniques to assess the tumor microenvironment. My current research program evolved from a project investigating chronic oral bicarbonate administration in tumor bearing mice to inhibit the spread of metastases. The study was the basis of a mentored career award from the National Center for Complementary and Alternative Medicine (NCCAM). The objective of my project is to advance the preclinical findings on the effects of tumor alkalinization to promote the application of eventual clinical trials with the expectation of establishing a research program bridging integrative medicine and diagnosis/therapy driven non-invasive imaging methodologies.

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top